Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Dec;85(12):1304–1311. doi: 10.1111/j.1349-7006.1994.tb02944.x

Differential Effect of Duocarmycin A and Its Novel Derivative DU‐86 on DNA Strand Breaks in HeLa S3 Cells

Akihiko Okamoto 1, Akira Asai 1, Hiromitsu Saito 1, Masami Okabe 1, Katsushige Gomi 1,✉
PMCID: PMC5919396  PMID: 7852193

Abstract

Duocarmycin A (DUMA) and DU‐86, a semisynthetic derivative of duocarmycins (DUMs) and a possible active form of KW‐2189, both showed potent cell growth‐inhibitory and cell‐killing activities against human uterine cervix carcinoma HeLa 83 cells. Both drugs showed similar profiles of inhibition of macromolecular synthesis and influence on cell‐cycle distribution. Namely, they inhibited [3H]thymidine uptake at lower concentrations than [3H]uridine or [3H]Ieucine uptake, suggesting that the inhibition of DNA synthesis is the primary site of their actions. Furthermore, they induced the accumulation of cells in early S phase. However, a significant difference was observed between these drugs in terms of DNA‐fragmentation activity against HeLa S3 cells by using two independent methods, pulse‐field gel electrophoresis and alkaline elution. DNA fragmentation was insignificant in the cells treated with DU‐86, in contrast to the cells treated with DUMA. The analysis of DNA adducts in the cells revealed that DU‐86 alkylated adenine quite selectively, while DUMA alkylated both adenine and guanine. These results suggest that the pyrrolidone ring of DUMA is responsible for its adduct formation with guanine and the subsequent DNA‐fragmentation and inhibition of DNA synthesis, while DU‐86 alkylated adenine and inhibited DNA synthesis through mechanisms other than DNA‐fragmentation.

Keywords: Duocarmycin A, DU‐86, DNA fragmentation

Full Text

The Full Text of this article is available as a PDF (475.5 KB).

REFERENCES

  • 1. ) Ogawa , T. , Ichimura , M. , Katsumata , S. , Morimoto , M. and Takahashi , K.New antitumor antibiotics, duocar‐mycin BI and B2 . J. Antibiot. , 42 , 1299 – 1301 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Takahashi , I. , Takahashi , K. , Ichimura , M. , Morimoto , M. , Asano , K. , Kawamoto , I. , Tomita , F. and Nakano , H.Duocarmycin A, a new antitumor antibiotic from Streptomyces . J. Antibiot. , 41 , 1915 – 1917 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Gomi , K. , Kobayashi , E. , Miyoshi , K. , Ashizawa , T. , Okamoto , A. , Ogawa , T. , Katsumata , S. , Mihara , A. , Okabe , M. and Hirata . T.Anticellular and antitumor activity of duocarmycins, novel antitumor antibiotics . Jpn. J. Cancer Res. , 83 , 113 – 120 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Sugiyama , H. , Hosoda , M. , Saito , I. , Asai , A. and Saito , H.Covalent alkylation of DNA with duocarmycin A. Identification of abasic site structure . Tetrahedron Lett. , 31 , 7197 – 7200 ( 1990. ). [PubMed] [Google Scholar]
  • 5. ) Sugiyama , H. , Ohmori , K. , Chan , K. L. , Hosoda , M. , Asai , A. , Saito , H. and Saito , I.A novel guanine N3 alkylation by antitumor antibiotic duocarmycin A . Tetrahedron Lett. , 34 , 2179 – 2182 ( 1993. ). [PubMed] [Google Scholar]
  • 6. ) Okamoto , A. , Okabe , M. and Gomi , K.Analysis of DNA fragmentation in human uterine cervix carcinoma HeLa S3 cells treated with duocarmycins or other antitumor agents by pulse field gel electrophoresis , Jpn. J. Cancer Res. , 84 , 93 – 98 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. ) Kobayashi , E. , Okamoto , A. , Asada , M. , Okabe , M. , Nagamura , S. , Asai , A. , Saito , H. , Gomi , K. and Hirata , T.Characteristics of antitumor activity of KW‐2189, a novel water‐soluble derivative of duocarmycin, against murine and human tumors . Cancer Res. , 54 , 2404 – 2410 ( 1994. ). [PubMed] [Google Scholar]
  • 8. ) Zsido , T. J. , Woynarowski , J. M. , Baker , R. M. , Gawron , L. S. and Beerman , T. A.Induction of heat‐labile sites in DNA of mammalian cells by the antitumor alkylating drug CC‐1065 . Biochemistry , 30 , 3733 – 3738 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Lee , C. S. and Gibson , N. W.DNA damage and differential cytotoxicity produced in human carcinoma cells by CC‐1065 analogues, U‐73,975 and U‐77,779 . Cancer Res. , 51 , 6586 – 6591 ( 1991. ). [PubMed] [Google Scholar]
  • 10. ) Boger , D. L. , Ishizaki , T. , Zarrinmayeh , H. , Munk , S. A. , Kites , P. A. and Suntornwat , O.Duocarmycin‐pyrinda‐mycin DNA alkylation properties and identification, synthesis, and evaluation of agents incorporating the phar‐macophore of the duocarmycin‐pyrindamycin alkylation subunit. Identification of the CC‐1065‐duocarmycin common pharmacophore. . J.Am. Chem. Soc. , 112 , 8961 – 8971 ( 1990. ). [Google Scholar]
  • 11. ) Boger , D. L. , Ishizaki , T. , Zarrinmayeh , H. , Kitos , P. A. and Suntornwat , O.Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duo‐carmycin/pyrindamycin alkylation subunit: identification of the CC‐1065/duocarmycin common pharmacophore . J. Org. Chem. , 55 , 4499 – 4502 ( 1990. ). [Google Scholar]
  • 12. ) Saito , H. , Nagamura , S. , Asai , A. , Kanda , Y. , Kobayashi , E. and Gomi , K.Synthesis, antitumor activity and DNA alkylation of duocarmycin analogs. Development of KW‐2189 . Abstr. 203rd Natl. Meet. Am. Chem. Soc. , MEDI‐044 ( 1992. ).
  • 13. ) Gomi , K. , Morimoto , M. and Nakamizo , N.Characteristics of antiviral and anticellular activities of human re‐combinant interferonγ‐ . J. Jpn. J. Cancer Res. , 76 , 224 – 234 ( 1985. ). [PubMed] [Google Scholar]
  • 14. ) Ogasawara , H. , Nishio , K. , Takeda , Y. , Ohmori , T. , Kubota , N. , Funayama , Y. , Ohira , T. , Kuraishi , Y. , Isogai , Y. and Saijo , N.A novel antitumor antibiotic, KW‐2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells . Jpn. J. Cancer Res. , 85 , 418 – 425 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Hurley , L. H. , Reynolds , V. L. , Swenson , D. H. , Petzold , G. L. and Scahill , T. A.Reaction of the antitumor agents CC‐1065 with DNA: structure of a DNA adduct with DNA sequence specificity . Science , 226 , 843 – 844 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Bhuyan , B. K. , Newell , K. A. , Crampton , S. L. and Von Hoff , D. D.CC‐1065 (NSC 298223), a most potent anti‐tumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival . Cancer Res. , 42 , 3532 – 3537 ( 1982. ). [PubMed] [Google Scholar]
  • 17. ) Adams , E. G. , Badiner , G. J. and Bhuyan , B. K.Effects of U‐71,184 and several other CC‐1065 analogues on cell survival and cell cycle of Chinese hamster ovary cells , Cancer Res. , 48 , 109 – 116 ( 1988. ). [PubMed] [Google Scholar]
  • 18. ) Bhuyan , B. K. , Smith , K. S. , Adams , E. G. , Wallace , T. L. , Von Hoff , D. D. and Li , L. H.Adozelesin , a potent new alkylating agent: cell‐killing kinetics and cell‐cycle effects . Cancer Chemother. Pharmacol , 30 , 348 – 354 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Nguyen , H. N. , Sevin , B. U. , Averette , H. , Perras , J. , Ramos , R. and Donate , D.Spectrum of cell‐cycle kinetics of alkylating agent adozelesin in gynecological cancer cell lines: correlation with drug‐induced cytotoxicity . J.Cancer Res. Clin. Oncol , 118 , 515 – 522 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Maine , I. P. , Sun , D. , Hurley , L. H. and Kodadek , T.The antitumor agent CC‐1065 inhibits helicase‐catalyzed unwinding of duplex DNA . Biochemistry , 31 , 3968 – 3975 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Sun , D. and Hurley , L. H.Structure‐activity relationships of (+)‐CC‐1065 analogues in the inhibition of helicase‐catalyzed unwinding of duplex DNA . J. Med. Chem. , 35 , 1773 – 1782 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Sun , D. and Hurley , L. H.Effect of the (+)‐CC‐1065‐(JVS‐adenine)DNA adduct on in vitro DNA synthesis mediated by Escherichia coli DNA polymerase . Biochemistry , 31 , 2822 – 2829 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Sun , D. and Hurley , L. H.Inhibition of T4 DNA ligase activity (+)‐CC‐1065: demonstration of the importance of the stiffening effect and winding effects of (+)‐CC‐1065 on DNA . Anti-Cancer Drug Des. , 7 , 15 – 36 ( 1992. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES